Back to top

Citi downgrades Agilon Health to Sell on ‘too rich’ valuation

Citi analyst Daniel Grosslight downgraded Agilon Health (AGL) to Sell from Neutral with a price target of $105, up from $80. The firm sees a less f...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Agilon Health, Inc. (AGL)